Federal Circuit Affirms PTAB Finding that Claims for Blood Pressure Treatment are Obvious
Briefly

"Honeywell held that 'unexpected properties may cause what may appear to be an obvious composition to be nonobvious,' not that unexpected mechanisms of action must be found to make the known use of known compounds nonobvious." - Federal Circuit
The U.S. Court of Appeals for the Federal Circuit (CAFC) ruled in a precedential decision Wednesday that the Patent Trial and Appeal Board (PTAB) was correct to affirm a United States Patent and Trademark Office (USPTO) examiner's finding that the claims of U.S. Patent Application 15/131,442 were obvious in view of the prior art.
Read at IPWatchdog.com | Patents & Intellectual Property Law
[
add
]
[
|
|
]